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1135-145 Preoperative Diagnosis of Diabetes Affects Long-Term 
Outcome In Patients After Heart Transplantation 
Martin Czemv. Keziban Uenal, Daniel Zimpfer, Vedat Sahin, Andreas Zuckermann, Peter 
Fasching, Ernst Wolner, Michael Grimm, Department of Cardio-Thoracic Surgery- 
University of Vienna, Vienna, Austria. 
Background. To compare long-term outcome in patients with and without diabetes at the 
time of heart transplantation. 
Methods. A retrospective analysis of 773 consecutive adult patients who underwent pri- 
mary heart transplantation from 1986 through 2000 was conducted. The total population 
consisted of 633 patients without diabetes (male n=532; 84%) and 140 patients with dia- 
betes (male n=115; 82%). 
Results. Long-term survival rates of patients with diabetes mellitus were lower as com- 
pared with patients without (w/o) diabetes mellitus (survival at 10 years with diabetes: 
40% vs. w/o diabetes: 58%; log-rank=0.025). Both patient groups showed the same inci- 
dence of angiographically documented transplant coronary artery disease-TxCAD 
(TxCAD at 10 years with diabetes: 28% vs. w/o diabetes: 22%; n.s.). Patients with diabe- 
tes were older as compared with patients w/o diabetes (with diabetes: 54.9±6.8 vs. w/o 
diabetes: 49.7¢10.8a, p=0.0001 ) and showed a higher incidence of coronary artery dis- 
ease as indication for transplantation as compared with patients w/o diabetes ( with dia- 
betes: 52% vs. w/o diabetes: 30%; p=0.000t). In multivariate regression analysis, the 
presence of diabetes at the time of transplantation (HR 1.594; 95%CI 1.009-2.518; 
p=0.045) as well as the use of thymoglobulin induction therapy (HR 0.476; 95%CI 0.319- 
0.710; p=O.0003) were independent predictors affecting long-term survival. Female gen- 
der (HR 0.075; 95%CI 0.010-0.538; p=0.012) as well as thymoglobuline antibody induc- 
tion therapy (HR 0,586; 95%CI 0.359-0.957; p=0.033) were independent predictors 
affecting the development of TxCAD. Interestingly, diabetes did not exhibit any influence 
on the occurrence of TxCAD. 
Conclusion. The diagnosis of diabetes at the time of transplantation adversely affects 
long-term survival but not the occurrence of transplant coronary artery disease. The 
major limitation for patients with diabetes seems to be advanced age and a higher inci- 
dence of coronary artery disease resulting in an impairment of global organ function and 
consecutively, in a diminished physiologic reserve. 
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838FO-2 Temporal Evolution of Molecular, Functional, and 
Structural Phenotypea in a Tranegenlc Rabbit Model of 
Human Hypertrophic Cardiomyopathy 
Sharif F. Naaueh. Natalia Tsyboulev, Rajnikant Patel, Helen A. Kopelen, Tripti Halder, 
Silvia Lutucuta, Lorraine Salek, William A, Zoghbi, Miguel A. Quinones, Mark Entman, 
Robed Roberts, Ali J. Marian, Baylor College of Medicine, Houston, Texas. 
Hypertrophic ardiomyopathy (HCM) is a genetic disease with protean clinical and patho- 
logical phenotypes including left ventricular hypertrophy (LVH), myocyte disarray (MD), 
interstitial fibrosis (IF), heart failure, and sudden death. Slow evolution of phenotypes 
hampers determination of their temporal sequence in humans. We developed transgenic 
rabbits by cardiac-specific expression of ~myosin heavy chain-glutamine (MyHC-Q)403, 
known to cause HCM in humans. Transgenic rabbits exhibit LVH, MD, IF, and myocardial 
dysfunction. We determined temporal evolution of molecular, functional, and structural 
phenotypes in the ~MyHC-Q403 rabbits by performing serial M-mode, 2-D, Doppler 
echocardiogrephy and tissue Doppler imaging, histological staining of myocardial sec- 
tions, and immunoblotting for hypertrophic signaling kinases in 36 B-MyHC-Q 403 and 35 
non-transgenic rabbits at <6 (pre-puberty), 6-24 (adulthood), >24 (old) months of age. 
Compared to control rabbits, LV wall thickness increased progressively in the ~MyHC- 
Q403 rabbits (septel thickness: 2.4t-0.2, 2.8±0.5, and 3.1t-0.4, respectively, p<0.00t). End 
diastolic and end systolic diameters were increased and fractional shortening reduced 
progressively (p<0.05). Doppler indices of LV filling pressure and left atrial size were also 
increased progressively (<0.05). Myocardial contraction and relaxation velocities were 
decreased in ~MyHC-Q403, compared to controls, in all three age groups. IF increased 
progressively with aging (2.7 ± t .2, 7.6 ± 4.7, and 9.0 ± 1.7%, p=0.005). Myocyte disar- 
ray was present eady and did not change with aging (9.0 ± 4.2, 11.8 ± 3.8, 10.6 ± 4.0%). 
Myocardial velocities were reduced even in the absence of IF and MD. Expression of 
active but not ERK1/2 was increased in 6-24 months old rabbits. Expression levels of 
active and total p38, JNKs, and GTP bound Ras, Ract and Rhol were unchanged. 
Thus, myocardial dysfunction occurs early and in the absence IF and MD. Disarray pre- 
cedes LVH and IF, which are progressive. Preserved global systolic function evolves into 
progressive systolic dysfunction with LV and left atrial enlargement and increased filling 
pressures. 
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838FO-3 Volume Overload-Induced Cardiac Remodeling Is 
Exaggerated in Mice With Homozygous Deletion of the 
Atrial Natrluretlc Peptide Gene 
~1 i ,A.n Feno, Gilbert J. Perry, Suzanne Oparil, Yiu-Fai Chen, Tatsuhiko Mori, Tetsuya 
Hayashi, Yasushi Kitaure, University of Alabama at Birmingham, Birmingham, Alabama, 
Osaka Medical College, Japan. 
Previous studies of the pathogenesis of cardiac enlargement in mice with homozygous 
deletion of atdal natriuretic peptide (ANP-/-) or the type-A natriuretic peptide receptor 
gene (Nprl-/-) have been confounded by concomitant elevations in blood pressure (BP) 
in ANP-/- and Nprl-/- animals when fed standard diets. To test the hypothesis that dele- 
tion of the ANP gene alters cardiac structure at baseline and in response to volume over- 
load stress independent of BP, male ANP-/- mica and control wild type ANP+/+ mice 
were fed a low (0.05%) NaCI diet beginning at weaning. Mean arterial pressure (MAP) 
measure in conscious mice was not significantly different between genotypes (100.3+-2.7 
mmHg, n=9, in ANP-/-; 94.4±3.7 mmHg, n=10, in ANP+/+). After 5 weeks on the low 
NaCI diet, mice underwent placement of an aodo-caval fistula (ACF) or sham surgery 
(Sham) and were subjected to echooardiographic examination at 2 wks. ACF shunting 
assessed by a microsphere technique was similar in ANP-/- and ANP+/+ mice. Heads 
were weighed and subjected to electron microscopic examination. Results (means~SEM, 
n=4~5) were shown in Table. These findings indicated that ANP deletion results in biven- 
tricular enlargement and an exaggerated response to volume overload (ventricular 
enlargement, increased myocyte diameter and myoflbrillar lysis) independent of BP. This 
supports the hypothesis that ANP has direct antihypertrophic and cardioprotective 
actions in head. 
Sham ACF 
ANP-/- ANP+/+ ANP-/- ANP+/+ 
WH (mg) 136.3±12.4" 72.5¢3.9 267.0±16.6#* 152.0±14.2# <0.01 
LVEDD(mm) 3.0±0.1 3.1±0.1 4.8±0.2#* 4.2±0.2# 0.04 
LVESD (mm) 1,5+0.1 1.7±0.1 2,6±0.2#* 2.1¢0.2# 0.07 
WT(mm) 1.2±0.0 1,1¢0.1 1,7±0,2 #* 1.3±0.1 0.09 
MD (mm) 19.3±0.1" 16.0±0.6 26.9±0.6#* 21.2±1.5# 0.21 
ML 1+ 0 4+ 1+ 
WH - whole head weight, LVEDD - left ventdcular (LV) end diastolic dimension, LVESD 
- LV end systolic dimension, WT - LV wall thickness, MD - myocyte diameter, ML - myo- 
fibnllar lysis, # p<0,05 vs. respective Sham groups. * p<0,05 vs. respective ANP+/+ 
groups, AxG - p value, interaction between ACF x Genotype by 2 way ANOVA 
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838FO-4 Disruption of Leptln Signaling Contributes to Cardiac 
Hypertrophy Independently of Body Weight 
Lili A. Barouch, Dan E. Berkowitz, Joshua M. Hare, Johns Hopkins Hospital, Baltimore, 
Maryland. 
Introduction: Left ventricular hypertrophy (LVH), which is common in obesity, likely 
results from increased mechanical load, although neurohormonal signaling may partici- 
pate as well, Abnormal regulation of leptin, a neurohormone ssential to energy homeo- 
stasis, is implicated in the pathogenesis of obesity. Because leptin also has 
cardiovascular bioactivity, we tested the hypothesis that it may protect the heart from 
LVH. 
Methods'. We measured left ventricular (LV) wall thickness (VWT) and LV mass (LVM) 
with echocardiography in transgenic mice lacking laptin (Ob/Ob, n==15) or its receptor 
(Db/Db, n=10), and littermate controls at 2, 4, and 6 months of age and after 4-6 weeks 
of weight loss, 
Results: All mice had similar VWT and LVM at 2 months, Obesity developed by 6 
months in both Ob/Ob (67+3 vs. 36+3 g, P<0.0001) and Db/Db (62±7 vs. 37¢5 g, 
P<O.O001) mice vs. controls. At 6 months, LVH developed in both Ob/Ob (VWT 
0.75¢0.02 vs. 0.56±0.01 mm, P<0.0001; LVM 91+4 vs. 64±3 mg, P<0.0001) and Db/Db 
(VWT 0.80±0,03 vs. 0.58:L-0.01 mm, P<0.0001; LVM 105~9 vs. 77+4 mg, P<O.01) vs. 
controls. To separate the direct contribution of leptin deficiency from the mechanical 
effects of excess body weight, we induced weight loss in 6-month-old Ob/Ob mice either 
by exogenous leptin infusion (0.3 mog/g/day via subcutaneous osmotic pump, n=-5) or 
caloric restdction (n=5). Mice in both leptin and diet groups (33±3 g vs. 37±1 g, respec- 
tively, P=NS) lost similar weight compared to control (placebo infusion and food ad libi- 
turn, /1=5; 75±2 g, P<O.0001 vs. both weight loss groups). Leptin infusion completely 
reversed LVH (VWT 0.58±0.01 vs. 0.81±O.02 ram, ,°<0,001; LVM 70±4 vs. 96±3 mg, 
P<0,005) vs. control. In marked contrast, calorie-restricted mice had no regression of 
LVH (VWT 0.78t-0.01 mm; LVM 104:/:13 mg, P=NS vs. control for both) despite similar 
weight loss. 
Conclusion: Together these data show the effect of leptin on LV architecture is not due 
to weight loss alone, and suggest that leptin has direct anti-hypertrophic affects on the 
head. Disruption of leptin signaling may represent a novel mechanism in the develop- 
ment of LVH and related cardiovascular disorders. 
